REMEDIUMREMEDIUM1561-59362658-3534Joint-Stock Company Chicot1351Original Article2017 Events (from open information sources)ArticleEditorialnoemail@neicon.ru1512201813S81518032022Copyright © 2018,2018January state Minister of Health Veronika Skvortsova announced the launch of pilot projects on risk sharing with the participation of four drugs in Moscow, the Moscow region and the Kaluga region at the Gaidar Forum. During 2017, these projects have not been launched. FAS made a statement л against these projects as it considered that no adequate legal mechanisms were developed to implement the pilot projects. FAS also believes that the risk-sharing system can not be used for drugs that lost the patent protection, have any registered analogues, are included in the VED list (one of the drugs included in the pilot project did not meet these requirements). • Russia FAS published a report on the results of the second stage of the comparative analysis of prices for drugs for the treatment of HIV, hepatitis B and C, as well as antibacterial and anti-tuberculosis drugs used to treat patients with multidrug-resistant tuberculosis. The registered marginal manufacturer prices for 95 items were higher in Russia than in some reference countries. The second stage results led to a drop in prices for 266 items, which was, among other things, the consequence and voluntary initiative of the companies. Earlier, the registration prices for 112 drugs were reduced as a result of the first stage of price monitoring, which affected the Seven Nosologies Program and ended in 2016.ГК «ПРОТЕК»ФармстандартНацимбиоСотексМарафон ФармБиокадНоваМедикаСанофиЕГИСЗФАСбизнес